Omeprazole
From £12.99

10% OFF
All Treatments
Account
Overview
Account
Overview
Treatments
Account
Understanding the differences between omeprazole and ranitidine helps patients make informed decisions about acid reflux treatment. Since ranitidine was withdrawn from the UK market in 2019 due to safety concerns, omeprazole and other proton pump inhibitors have become the primary treatment options. Both medications work differently to reduce stomach acid, with omeprazole offering more potent and longer-lasting acid suppression for managing heartburn and GORD symptoms.
From £12.99

From £5.99

From £12.99

From £8.49

From £29.99

From £5.99

From £19.99

From £16.99

Omeprazole and ranitidine work through different mechanisms to reduce stomach acid production. Omeprazole is a proton pump inhibitor (PPI) that blocks the final step of acid production in stomach cells, whilst ranitidine was an H2 receptor antagonist that blocked histamine signals triggering acid release. This fundamental difference means omeprazole typically provides more comprehensive acid suppression.
The Medicines and Healthcare products Regulatory Agency (MHRA) withdrew ranitidine from the UK market in October 2019 after detecting NDMA (N-nitrosodimethylamine), a probable carcinogen, in many products. This withdrawal affected popular brands including Zantac, making omeprazole and other PPIs the primary treatment choice for acid reflux management.
Clinical studies demonstrate that omeprazole provides superior acid suppression compared to ranitidine. Omeprazole 20mg daily typically reduces stomach acid production by 90-95% within one week, whilst ranitidine achieved approximately 60-70% reduction. This enhanced effectiveness means many patients experience faster symptom relief with omeprazole treatment.
Following ranitidine's withdrawal, EverydayMeds offers several effective acid reflux treatments. Omeprazole 20mg capsules remain the most prescribed option, providing reliable symptom control for most patients. Losec MUPS 20mg tablets offer a branded alternative with the same active ingredient. For patients requiring different PPI options, lansoprazole 15mg capsules and pantoprazole 20mg tablets provide alternative mechanisms of action.
Patients who previously used ranitidine can consider famotidine tablets, another H2 receptor antagonist that remains safely available. Famotidine works similarly to ranitidine but without the contamination concerns, making it suitable for those preferring H2 blockers over PPIs. However, most healthcare professionals now recommend PPIs like omeprazole as first-line treatment due to superior effectiveness.
When selecting acid reflux medication, consider symptom severity, frequency, and treatment response. Omeprazole suits most patients with regular heartburn or diagnosed GORD, offering once-daily dosing convenience. Esomeprazole tablets provide an enhanced formulation for treatment-resistant cases, whilst famotidine offers a suitable alternative for patients experiencing PPI side effects. EverydayMeds' range ensures appropriate treatment options for varying patient needs and preferences.
Start your journey to better health today.
Once you complete a short online assessment, you’ll be able to choose your preferred treatment and quantity from a list of safe, medically approved options tailored to you.
Start My AssessmentReturning customer?
Log in to Your Account